COVID-19 Vaccine Updates for February 2021


A video breakdown of the past week's developments and news in leading vaccine candidates.

Vaccine segments

0:39 Moderna
1:54 Novavax
3:33 Johnson & Johnson
4:42 AstraZeneca
6:20 Pfizer - BioNTech
9:47 Sanofi

In just 5 short days last week, a series of news and developments from a half-dozen vaccine producers resulted in a shifting landscape of coronavirus 2019 (COVID-19) prevention.

The US is currently reporting steady drops in new daily cases and continued climbs in first vaccinations administered. But information on the distribution, investigation, and utility of the vaccines—especially given newly observed variants—is crucial to keep this progression.

Watch the video above to catch up on all that occurred in the last week of COVD-19 vaccine news and developments, product by product. From phase 3 data, to new federal regulations and updates on variant protection, both marketed and investigative vaccines have moved significantly in a short period of time.

Catch up on all of Contagion’s coverage on the COVID-19 Vaccine Race page.

Interested in learning more about a particular vaccine? Let us know below:

What COVID-19 vaccine are you interested in learning more about from Contagion?

BNT162b2 (Pfizer-BioNTech)
mRNA-1273 (Moderna)
AZD1222 (AstraZeneca)
NVX-CoV2373 (Novavax)
JNJ-78436735 (Johnson & Johnson)
The Sanofi mRNA vaccine
Recent Videos
© 2024 MJH Life Sciences

All rights reserved.